ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,783 | -52.5% | 1,692,053 | -33.3% | 0.01% | -45.8% |
Q2 2023 | $16,386 | -22.7% | 2,536,603 | -9.8% | 0.02% | -14.3% |
Q1 2023 | $21,199 | -1.4% | 2,811,503 | +32.5% | 0.03% | -3.4% |
Q4 2022 | $21,500 | -99.9% | 2,122,403 | -28.8% | 0.03% | -31.0% |
Q3 2022 | $29,480,000 | -31.4% | 2,980,803 | -26.2% | 0.04% | -17.6% |
Q2 2022 | $42,987,000 | +68.4% | 4,036,303 | +54.2% | 0.05% | +70.0% |
Q1 2022 | $25,522,000 | +231.0% | 2,617,603 | +385.5% | 0.03% | +200.0% |
Q4 2021 | $7,711,000 | +356.5% | 539,203 | +539.6% | 0.01% | +400.0% |
Q3 2021 | $1,689,000 | -81.0% | 84,300 | -79.1% | 0.00% | -81.8% |
Q2 2021 | $8,870,000 | – | 403,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |